These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17347668

  • 1. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
    Sirach E, Bureau C, Péron JM, Pradayrol L, Vinel JP, Buscail L, Cordelier P.
    Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
    [Abstract] [Full Text] [Related]

  • 2. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC, Chen Z, Chen F, Chen XH, Jin HY, Xu XY.
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [Abstract] [Full Text] [Related]

  • 4. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
    Zhang D, Liu J, Wang Y, Chen J, Chen T.
    J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
    [Abstract] [Full Text] [Related]

  • 5. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [Abstract] [Full Text] [Related]

  • 6. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G, Kremer-Tal S, Matsumoto N, Zhao X, Yao S, Kelley K, Tarocchi M, Friedman SL.
    Oncogene; 2007 Jun 28; 26(30):4428-34. PubMed ID: 17297474
    [Abstract] [Full Text] [Related]

  • 7. Silibinin efficacy against human hepatocellular carcinoma.
    Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R.
    Clin Cancer Res; 2005 Dec 01; 11(23):8441-8. PubMed ID: 16322307
    [Abstract] [Full Text] [Related]

  • 8. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y, Hu MY, Chen BH, Wang ZJ, Zha XL, Liu KD.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):530-5. PubMed ID: 16681881
    [Abstract] [Full Text] [Related]

  • 9. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
    Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, Katz A, Bruix J, Bioulac-Sage P, Martignetti JA, Friedman SL.
    Hepatology; 2004 Nov 28; 40(5):1047-52. PubMed ID: 15486921
    [Abstract] [Full Text] [Related]

  • 10. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X.
    Cancer Res; 2003 Dec 01; 63(23):8323-9. PubMed ID: 14678992
    [Abstract] [Full Text] [Related]

  • 11. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 12. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J, Kim CJ, Cho YG, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.
    J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1286-9. PubMed ID: 16872311
    [Abstract] [Full Text] [Related]

  • 13. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 14. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J, Shen F, Wu D, Wei LX, Wang YZ, Shi LH, Zou Y, Wu MC.
    Oncol Rep; 2007 May 01; 17(5):1067-75. PubMed ID: 17390046
    [Abstract] [Full Text] [Related]

  • 15. [A candidate tumor suppressor gene mutated in primary hepatocellular carcinoma: kruppel-like factor 6].
    Wang SP, Chen XP, Qiu FZ.
    Zhonghua Wai Ke Za Zhi; 2004 Oct 22; 42(20):1258-61. PubMed ID: 15598377
    [Abstract] [Full Text] [Related]

  • 16. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O, Kawabe T, Hasegawa Y, Shimokata K, Sekido Y.
    Cancer Res; 2004 Jun 01; 64(11):3838-43. PubMed ID: 15172991
    [Abstract] [Full Text] [Related]

  • 17. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.
    Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499
    [Abstract] [Full Text] [Related]

  • 18. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW.
    Int J Oncol; 2009 Dec 15; 35(6):1257-64. PubMed ID: 19885547
    [Abstract] [Full Text] [Related]

  • 19. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
    Che Y, Ye F, Xu R, Qing H, Wang X, Yin F, Cui M, Burstein D, Jiang B, Zhang DY.
    Am J Pathol; 2012 May 15; 180(5):1798-807. PubMed ID: 22429965
    [Abstract] [Full Text] [Related]

  • 20. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC, Chi CW, Chau GY, Li FY, Tsai YH, Wu JC, Wu Lee YH.
    Oncogene; 2006 Mar 30; 25(14):1991-2003. PubMed ID: 16301996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.